✦ LIBER ✦

Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species

✍ Scribed by Steven E. Rowland; Patsy Clark; Robert Gordon; Anne K. Mullen; Jocelyne Guay; Lynn Dufresne; Christine Brideau; Bernard Cote; Yves Ducharme; Joseph Mancini; Chi-chung Chan; Laurent Audoly; Daigen Xu

Book ID: 113586705
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 1006 KB
Volume: 560
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2007.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Synthesis and Biolo

ChemInform Abstract: Synthesis and Biological Evaluation of 3-Heteroaryloxy-4-phenyl-2(5H)-furanones as Selective Cox-2 Inhibitors.

✍ Cheuk K. Lau; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

Sulfonamido, Azidosulfonyl and N-Acetyls

Sulfonamido, Azidosulfonyl and N-Acetylsulfonamido Analogues of Rofecoxib: 4-[4-(N-Acetylsulfonamido)phenyl] -3-(4-methanesulfonylphenyl)-2(5H)furanone is a Potent and Selective Cyclooxygenase-2 Inhibitor.

✍ Afshin Zarghi; P. N. Praveen Rao; Edward E. Knaus 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 150 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

ChemInform Abstract: Synthesis of Rofeco

ChemInform Abstract: Synthesis of Rofecoxib, (MK 0966, Vioxx® 4-(4′-Methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a Selective and Orally Active Inhibitor of Cyclooxygenase-2.

✍ Michel Therien; Jacques Yves Gauthier; Yves Leblanc; Serge Leger; Helene Perrier 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

Preclinical pharmacokinetics and metabol

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

✍ Amit S. Kalgutkar; Heather L. Hatch; Frederick Kosea; Hang T. Nguyen; Edna F. Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 2 views

In vitro and in vivo pharmacological cha

In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V1A receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)

✍ Rachel Russell; Rachel Doyle; Jamie Turner; Neil Attkins; Simeon Ramsey; Laura W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 786 KB

In Vitro Structure−Activity Relationship

In Vitro Structure−Activity Relationship and in Vivo Studies for a Novel Class of Cyclooxygenase-2 Inhibitors: 5-Aryl-2,2-dialkyl-4-phenyl-3(2 H )furanone Derivatives

✍ Shin, Song Seok; Byun, Youngjoo; Lim, Kyung Min; Choi, Jin Kyu; Lee, Ki-Wha; Moh 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 260 KB